Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $95,240 - $144,179
11,995 New
11,995 $138,000
Q3 2022

Nov 14, 2022

SELL
$3.93 - $8.57 $34,815 - $75,921
-8,859 Reduced 38.91%
13,908 $81,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $91,523 - $237,459
22,767 New
22,767 $101,000
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $82,943 - $102,391
-16,622 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$5.92 - $7.41 $98,402 - $123,169
16,622 New
16,622 $101,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.